Search - tctmd.com

Displaying 1 - 20 of 25

Sort: Relevancy | Date

No Additional Gain in Quality of Life With Dapagliflozin on Top of TAVI

Todd Neale

May 20, 2025

News Conference News ACC 2025

Dapagliflozin Works Well for High-Risk TAVI Patients With HF: DapaTAVI

Caitlin E. Cox

March 30, 2025

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for April 2021

Caitlin E. Cox

May 03, 2021

News Features

Year in Review: SGLT2 Inhibition, Lipid-Lowering Make Waves in Clinical Cardiology in 2019

Todd Neale

December 10, 2019

News Daily News

TAVR Bleeds Stand Apart From PCI-Related Events

Caitlin E. Cox

August 06, 2019

News Conference News CRT 2018

Ticagrelor: Better Platelet Blockade Post-TAVR?

Michael O'Riordan

March 07, 2018

News Conference News EuroPCR 2017

My Takeaways From EuroPCR 2017: Everything Perfect, Until It’s Not

Shelley Wood

June 02, 2017

News Conference News EuroPCR 2017

EuroPCR 2017: New Stents, New Questions for PCI Today and Tomorrow as Angioplasty Turns 40

Shelley Wood

May 12, 2017

News Daily News

TCTMD’s Top 10 Most Popular Stories for July 2016

Shelley Wood

July 28, 2016

News Daily News

Bajan los Índices de ACV y Aumentan las Dudas sobre los Dispositivos de Protección Embólica en las Intervenciones TAVR

Michael O'Riordan

March 14, 2016

News Daily News

Year in Review: Physicians Select the Most Important News of 2015, in Interventional Cardiology and Beyond

December 23, 2015

News Features

当天出院TAVR：反常还是未来的浪潮？

L.A. McKeown

August 27, 2015

News Daily News

Subanálisis del Ensayo CoreValve norteamericano: Solo la TAVR Femoral Ofrece una Ventaja en la Calidad de Vida Precoz sobre la Cirugía

L.A. McKeown

August 19, 2015

News Daily News

CoreValve美国亚组分析：仅有股动脉TAVR表现出相对于外科手术的早期生活质量优势

L.A. McKeown

August 19, 2015

News Daily News

CoreValve US Subanalysis: Only Femoral TAVR Offers Early QoL Advantage Over Surgery

L.A. McKeown

August 19, 2015

News Daily News

Survival Benefit of CoreValve in High-Risk Patients Persists at 2 Years

July 07, 2015

News Daily News

El Beneficio sobre la Supervivencia de CoreValve en Pacientes de Alto Riesgo se Mantiene a los 2 Años

July 07, 2015

News Daily News

CoreValve在高风险患者中的生存益处到2年时依然持续存在

July 07, 2015

News Daily News

之前无明确冠心病的患者中 CTO 相对常见

Nicole Lou

June 30, 2015

News Daily News

Las OTC son Relativamente Frecuentes en Pacientes Sin EAC Conocida Anteriormente

Nicole Lou

June 30, 2015

Advertisement

No Additional Gain in Quality of Life With Dapagliflozin on Top of TAVI

Dapagliflozin Works Well for High-Risk TAVI Patients With HF: DapaTAVI

TCTMD’s Top 10 Most Popular Stories for April 2021

Year in Review: SGLT2 Inhibition, Lipid-Lowering Make Waves in Clinical Cardiology in 2019

TAVR Bleeds Stand Apart From PCI-Related Events

Ticagrelor: Better Platelet Blockade Post-TAVR?

My Takeaways From EuroPCR 2017: Everything Perfect, Until It’s Not

EuroPCR 2017: New Stents, New Questions for PCI Today and Tomorrow as Angioplasty Turns 40

TCTMD’s Top 10 Most Popular Stories for July 2016

Bajan los Índices de ACV y Aumentan las Dudas sobre los Dispositivos de Protección Embólica en las Intervenciones TAVR

Year in Review: Physicians Select the Most Important News of 2015, in Interventional Cardiology and Beyond

当天出院TAVR：反常还是未来的浪潮？

Subanálisis del Ensayo CoreValve norteamericano: Solo la TAVR Femoral Ofrece una Ventaja en la Calidad de Vida Precoz sobre la Cirugía

CoreValve美国亚组分析：仅有股动脉TAVR表现出相对于外科手术的早期生活质量优势

CoreValve US Subanalysis: Only Femoral TAVR Offers Early QoL Advantage Over Surgery

Survival Benefit of CoreValve in High-Risk Patients Persists at 2 Years

El Beneficio sobre la Supervivencia de CoreValve en Pacientes de Alto Riesgo se Mantiene a los 2 Años

CoreValve在高风险患者中的生存益处到2年时依然持续存在

之前无明确冠心病的患者中 CTO 相对常见

Las OTC son Relativamente Frecuentes en Pacientes Sin EAC Conocida Anteriormente

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content